BioNanoNet (BNN), which performs as third party of NANOfutures, is a scientific network that specializes in the Key Enabling Technologies nanotechnology and biotechnology located in Austria, with the emphasis on (1) nanotoxicology, (2) sensortechnologies, as well as (3) health, (nano-)safety and (nano-)medicine, and additionally supports projects in coordination, management, dissemination and communication.
BNN is a European key player in the field of nano-safety, specialised in developing nano-safety-by-design strategies together with researchers and industry, and coordinator of international nano-safety and nano-innovation activities (e.g., Industrial Innovation Liaisons, Closer-To-The-Market, etc.).
BNN has the clear aim of driving innovative interdisciplinary research by supporting the cooperation by bringing together scientific experts and industry to gain critical mass for thematic areas, to initiate, set up and manage national as well as international research projects and to add value by providing nano-safety strategies tailored to the needs of organisations. Therefore, BioNanoNet continuously interacts with national and international stakeholders, as well as policy makers and regulatory and legislative authorities (e.g., in the context of NANoREG, EURO-NanoTox, standardisation committees, etc.).